Hydropothecary
(TSX VENTURE: $THCX.V) Announces Release Of Honeydew, One Of Canada's Highest
Legal CBD:THC Ratio Products To Date
GATINEAU, QC - August 15, 2017
(Investorideas.com Newswire) The Hydropothecary Corporation (TSX VENTURE: THCX)
(the "Company" or "Hydropothecary") is pleased to announce
it has started shipping Honeydew, the Company's highest CBD:THC ratio product
offering to date.
Part of the Company's mid-market
H2 product line, the dried bud has a ratio of 18.5 percent CBD to 1.8 percent
THC, making it one of the highest CBD products available under Health Canada's
regulations.
Read this news in
full at http://www.investorideas.com/news/2017/marijuana/08151Hydropothecary.asp
Watch the 420 Cannabis Investor
video
Marijuana /
Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp
Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp
Stocks - News and Trends in Green Investing
This
news is published on the Investorideas.com Newswire - a global digital news
source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investment involves
risk and possible loss of investment. This site is currently compensated for
news publication and distribution, social media and marketing, content creation
and more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment